由于177Lu-PSMA外注引起的辐射引起的皮肤副作用:一个案例报告
Heather Corveleyn1, Lynn De Mey, Laurens Raes
1Dienst Nucleaire Geneeskunde, UZ Brussel, Jette, Belgium.
Clinical nuclear medicine
|February 16, 2026
概括
一位患者经历了卢-177 PSMA (177Lu-PSMA) 扩散的副作用,包括和皮肤变化. 症状在注射后9周内消失,这凸显了对此类不良事件的监测的重要性.
科学领域:
- 核医学就是核医学.
- 放射性药物疗法是一种放射性药物疗法.
- 皮肤病学 皮肤病学
背景情况:
- 卢-177 PSMA (177Lu-PSMA) 治疗是一种针对前列腺癌的向治疗.
- 在静脉注射期间,外流,即注射物质到周围组织的泄漏,可能会发生.
- 了解177Lu-PSMA扩散的潜在副作用对于患者管理至关重要.
研究的目的:
- 报告一个由177Lu-PSMA扩散引起的临床副作用的病例.
- 描述观察到的不良事件的时间表和性质.
- 为管理177Lu-PSMA治疗并发症的知识库做出贡献.
主要方法:
- 一名接受177Lu-PSMA治疗的患者在通过肘部静脉给药时经历了外流.
- 注射后的管理包括手臂升高和动员.
- 在9周内进行了临床观察和随访.
主要成果:
- 患者在注射后五周出现局部.
- 观察到一个红血状斑块与 lichenification.
- 在9周后,轻微的炎症性多色素持续存在,其他症状消失.
结论:
- 177Lu-PSMA的扩散可以导致局部皮肤副作用.
- 和皮肤变化等症状是可以控制的,并且通常会随着时间的推移而消失.
- 密切监测和适当的患者指导在177Lu-PSMA给药后很重要.
相关概念视频
02:59Biological Effects of Radiation
18.1K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
18.1K
01:30Skin Cancer
6.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.1K